Hostname: page-component-8448b6f56d-t5pn6 Total loading time: 0 Render date: 2024-04-17T18:58:26.431Z Has data issue: false hasContentIssue false
  • English
  • Français

Remote delivery of psychological interventions for Parkinson's disease

Published online by Cambridge University Press:  11 May 2018

Caitlin Swalwell ,
Nancy A. Pachana  and
Nadeeka N. Dissanayaka
Caitlin Swalwell
Affiliation:
School of Psychology, The University of Queensland, Brisbane, Australia UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia
Nancy A. Pachana
Affiliation:
School of Psychology, The University of Queensland, Brisbane, Australia
Nadeeka N. Dissanayaka*
Affiliation:
School of Psychology, The University of Queensland, Brisbane, Australia UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia Department of Neurology, Royal Brisbane & Woman's Hospital, Brisbane, Australia
*
Correspondence should be addressed to: Nadeeka N. Dissanayaka, UQ Centre for Clinical Research, Royal Brisbane & Woman's Hospital, 71/918 Herston, Brisbane, QLD 4029, Australia. Phone: +61-7-33465577; Fax: +61-7-33465599. Email: n.dissanayaka@uq.edu.au.
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

Over two-thirds of Parkinson's disease (PD) patients experience comorbid neuropsychiatric symptoms, which adversely impact their quality of life and often require intervention. There is a preference for non-pharmacological, psychological approaches in addressing these symptoms. Given mobility limitations, travel burden, and cost, accessibility to psychological treatment can be problematic in this population. There has been a recent shift toward delivering care via telehealth in PD. Accordingly, this review aimed to examine remotely delivered psychological interventions for PD patients.

Results:

Most of the telehealth studies for PD involved Cognitive Behavioral Therapy (CBT) based anxiety and depression telephone interventions with relatively short (one month) follow-up periods.

Conclusion:

Although a preliminary work indicates efficacy, future studies should demonstrate the non-inferiority of these telehealth programs compared to face-to-face delivery, and examine the long-term outcomes of remotely delivered therapy. Video-conferencing (VC) appears to be a promising modality to overcome noted limitations of telephone delivery, and has demonstrated efficacy for PD speech programs. Further research should be conducted evaluating telehealth VC modalities for delivery of psychotherapy including CBT, as well as mindfulness-based therapy and acceptance and commitment therapy for remote treatment of depression and anxiety in PD.

Keywords

Parkinson's diseasetelehealthdepressionanxietycognitive behavioral therapy
Type
Review Article
Information
International Psychogeriatrics , Volume 30 , Issue 12: Issue Theme: Positive Psychiatry , December 2018 , pp. 1783 - 1795
Copyright
Copyright © International Psychogeriatric Association 2018 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aarsland, D. et al. (1999). Range of neuropsychiatric disturbances in patients with Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 67, 492–496.Google Scholar
Achey, M. A. et al. (2014). Virtual house calls for Parkinson disease (Connect.Parkinson): study protocol for a randomized, controlled trial. Trials, 15, 465.Google Scholar
Advocat, J., Enticott, J., Vandenberg, B., Hassed, C., Hester, J. and Russell, G. (2016). The effects of a mindfulness-based lifestyle program for adults with Parkinson's disease: a mixed methods, wait list controlled randomised control study. BMC Neurology, 16, 166.Google Scholar
Barbour, P. J., Arroyo, J., High, S., Fichera, L. B., Staska-Pier, M. M. and McMahon, M. K. (2016). Telehealth for patients with Parkinson's disease: delivering efficient and sustainable long-term care. Hospital Practice (1995), 44, 92–97.Google Scholar
Benito-Leon, J., Cubo, E. and Coronell, C. (2012). Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: the ANIMO study. Movement Disorders, 27, 211–218.Google Scholar
Broen, M. P., Narayen, N. E., Kuijf, M. L., Dissanayaka, N. N. and Leentjens, A. F. (2016). Prevalence of anxiety in Parkinson's disease: A systematic review and meta-analysis. Movement Disorders, 31, 1125–1133.Google Scholar
Butterfield, L. C., Cimino, C. R., Salazar, R., Sanchez-Ramos, J., Bowers, D. and Okun, M. S. (2016). The Parkinson's Active Living (PAL) Program: a behavioral intervention targeting apathy in Parkinson's disease. Journal of Geriatric Psychiatry and Neurology, 30, 11–25.Google Scholar
Calleo, J. S. et al. (2015). A pilot study of a cognitive-behavioral treatment for anxiety and depression in patients with Parkinson disease. Journal of Geriatric Psychiatry and Neurology, 28, 210–217.Google Scholar
Cash, T. V., Ekouevi, V. S., Kilbourn, C. and Lageman, S. K. (2016). Pilot study of a mindfulness-based group intervention for individuals with Parkinson's disease and their caregivers. Mindfulness, 7, 361–371.Google Scholar
Chen, J. J. and Marsh, L. (2014). Anxiety in Parkinson's disease: identification and management. Therapeutic Advances in Neurological Disorders, 7, 52–59.Google Scholar
Constantinescu, G. A., Theodoros, D. G., Russell, T. G., Ward, E. C., Wilson, S. J. and Wootton, R. (2010). Home-based speech treatment for Parkinson's disease delivered remotely: a case report. Journal of Telemedicine and Telecare, 16, 100–104.Google Scholar
Constantinescu, G. A., Theodoros, D. G., Russell, T. G., Ward, E. C., Wilson, S. J. and Wootton, R. (2011). Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non‐inferiority trial. International Journal of Language & Communication Disorders, 46, 1–16.Google Scholar
den Brok, M. G., van Dalen, J. W., van Gool, W. A., Moll van Charante, E. P., de Bie, R. M. and Richard, E. (2015). Apathy in Parkinson's disease: a systematic review and meta-analysis. Movement Disorders, 30, 759–769.Google Scholar
Dias, A. E., Limongi, J. C., Barbosa, E. R. and Hsing, W. T. (2016). Voice telerehabilitation in Parkinson's disease. CoDas, 28, 176–181.Google Scholar
Dissanayaka, N. N. et al. (2010). Anxiety disorders in Parkinson's disease: prevalence and risk factors. Movement Disorders, 25, 838–845.Google Scholar
Dissanayaka, N. N. et al. (2016a). Mindfulness for motor and non-motor dysfunctions in Parkinson's disease. Parkinson's Disease, 2016, 7109052.Google Scholar
Dissanayaka, N. N. et al. (2016b). Disease-specific anxiety symptomatology in Parkinson's disease. International Psychogeriatrics, 28, 1153–1163.Google Scholar
Dissanayaka, N. N., Torbey, E. and Pachana, N. A. (2015). Anxiety rating scales in Parkinson's disease: a critical review updating recent literature. International Psychogeriatrics, 27, 1777–1784.Google Scholar
Dobkin, R. D. et al. (2011a). Cognitive behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial. The American Journal of Psychiatry, 168, 1066–1074.Google Scholar
Dobkin, R. D. et al. (2011b). Telephone-based cognitive-behavioral therapy for depression in Parkinson disease. Journal of Geriatric Psychiatry and Neurology, 24, 206–214.Google Scholar
Dobkin, R. D. et al. (2014). Neuropsychological outcomes following psychosocial intervention for depression in Parkinson's disease. The Journal of Neuropsychiatry and Clinical Neurosciences, 26, 57–63.Google Scholar
Dobkin, R. D. (2014). The relationship between telephone-administered cognitive-behavioral therapy for depression and neuropsychological functioning in Parkinson's disease. The Journal of Neuropsychiatry and Clinical Neurosciences, 26, E10–11.Google Scholar
Dobkin, R. D., Allen, L. A. and Menza, M. (2007). Cognitive-behavioral therapy for depression in Parkinson's disease: a pilot study. Movement Disorders, 22, 946–952.Google Scholar
Dobkin, R. D., Rubino, J. T., Friedman, J., Allen, L. A., Gara, M. A. and Menza, M. (2013). Barriers to mental health care utilization in Parkinson's disease. Journal of Geriatric Psychiatry and Neurology, 26, 105–116.Google Scholar
Dorsey, E. R. et al. (2013). Randomized controlled clinical trial of “virtual house calls” for Parkinson disease. JAMA Neurology, 70, 565–570.Google Scholar
Feeney, F., Egan, S. and Gasson, N. (2005). Treatment of depression and anxiety in Parkinson's disease: a pilot study using group cognitive behavioral therapy. Clinical Psychologist, 9, 31–38.Google Scholar
Fitzpatrick, L., Simpson, J. and Smith, A. (2010). A qualitative analysis of mindfulness-based cognitive therapy (MBCT) in Parkinson's disease. Psychology and Psychotherapy, 83, 179–192.Google Scholar
Frisina, P. G., Borod, J. C., Foldi, N. S. and Tenenbaum, H. R. (2008). Depression in Parkinson's disease: health risks, etiology, and treatment options. Neuropsychiatric Disease and Treatment, 4, 81–91.Google Scholar
Ghielen, I. et al. (2015). BEWARE: Body awareness training in the treatment of wearing-off related anxiety in patients with Parkinson's disease: study protocol for a randomized controlled trial. Trials, 16, 283.Google Scholar
Hughes, T. A., Ross, H. F., Mindham, R. H. and Spokes, E. G. (2004). Mortality in Parkinson's disease and its association with dementia and depression. Acta Neurologica Scandinvica, 110, 118–123.Google Scholar
Jiang, J. L., Tsai, S. T., Hsieh, T. C., Lee, C. W., Lin, S. H. and Chen, S. Y. (2013). The impact of motor and depressive symptoms on quality of life in patients with Parkinson's disease. Tzu Chi Medical Journal, 25, 175–178.Google Scholar
Kraepelien, M., Svenningsson, P., Lindefors, N. and Kaldo, V. (2015). Internet-based cognitive behavioral therapy for depression and anxiety in Parkinson's disease—a pilot study. Internet Interventions, 2, 1–6.Google Scholar
Laatu, S., Karrasch, M., Martikainen, K. and Marttila, R. (2013). Apathy is associated with activities of daily living ability in Parkinson's disease. Dementia and Geriatric Cognitive Disorders, 35, 249–255.Google Scholar
Lawson, R. A., Millar, D., Brown, R. G. and Burn, D. J. (2013). Guided self-help for the management of worry in Parkinson's disease: a pilot study. Journal of Parkinson's Disease, 3, 61–68.Google Scholar
Lubomski, M., Rushworth, R. L., Lee, W., Bertram, K. and Williams, D. R. (2013). A cross-sectional study of clinical management, and provision of health services and their utilisation, by patients with Parkinson's disease in urban and regional Victoria. Journal of Clinical Neuroscience, 20, 102–106.Google Scholar
Martinez-Martin, P., Rodrigeuz-Blazquez, C., Kurtis, M. M. and Chaudhuri, K. R. (2011). The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease. Movement Disorders, 26, 399–406.Google Scholar
Menon, B. et al. (2015). Parkinson's disease, depression, and quality-of-life. Indian Journal of Psychological Medicine, 37, 144–148.Google Scholar
Okai, D. et al. (2013). Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers. Neurology, 80, 792–799.Google Scholar
Pachana, N. A. et al. (2013). Clinical issues in the treatment of anxiety and depression in older adults with Parkinson's disease. Movement Disorders, 28, 1930–1934.Google Scholar
Pickut, B. et al. (2015). Mindfulness training among individuals with Parkinson's disease: neurobehavioral effects. Parkinson's Disease, 2015, 816404.Google Scholar
Price, A. et al. (2011). Antidepressants for the treatment of depression in neurological disorders: a systematic review and meta-analysis of randomised controlled trials. Journal of Neurology, Neurosurgery, and Psychiatry, 82, 914–923.Google Scholar
Quelhas, R. and Costa, M. (2009). Anxiety, depression, and quality of life in Parkinson's disease. The Journal of Neuropsychiatry and Clinical Neurosciences, 21, 413–419.Google Scholar
Rabinstein, A. A. and Shulman, L. M. (2000). Management of behavioral and psychiatric problems in Parkinson's disease. Parkinsonism & Related Disorders, 7, 41–50.Google Scholar
Rahman, S., Griffin, H. J., Quinn, N. P. and Jahanshahi, M. (2008). Quality of life in Parkinson's disease: the relative importance of the symptoms. Movement Disorders, 23, 1428–1434.Google Scholar
Reijnders, J. S., Ehrt, U., Weber, W. E., Aarsland, D. and Leentjens, A. F. (2008). A systematic review of prevalence studies of depression in Parkinson's disease. Movement Disorders, 23, 183–189; quiz 313.Google Scholar
Riedel, O. et al. (2010). Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease. Journal of Neurology, 257, 1073–1082.Google Scholar
Schrag, A. (2006). Quality of life and depression in Parkinson's disease. Journal of the Neurological Sciences, 248, 151–157.Google Scholar
Schrag, A., Jahanshahi, M. and Quinn, N. (2000). What contributes to quality of life in patients with Parkinson's disease? Journal of Neurology, Neurosurgery, and Psychiatry, 69, 308–312.Google Scholar
Shinmei, I. et al. (2016). Cognitive behavioral therapy for depression in Japanese Parkinson's disease patients: a pilot study. Neuropsychiatric Disease and Treatment, 12, 1319–1331.Google Scholar
Theodoros, D. G., Hill, A. J. and Russell, T. G. (2016). Clinical and quality of life outcomes of speech treatment for Parkinson's disease delivered to the home via telerehabilitation: a non-inferiority randomized controlled trial. American Journal of Speech-Language Pathology, 25, 214–232.Google Scholar
Troeung, L., Egan, S. J. and Gasson, N. (2013). A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson's disease. PLoS One, 8, e79510.Google Scholar
Troeung, L., Egan, S. J. and Gasson, N. (2014). A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson's disease. BMC Psychiatry, 14, 19.Google Scholar
Veazey, C., Aki, S. O., Cook, K. F., Lai, E. C. and Kunik, M. E. (2005). Prevalence and treatment of depression in Parkinson's disease. The Journal of Neuropsychiatry and Clinical Neurosciences, 17, 310–323.Google Scholar
Veazey, C., Cook, K. F., Stanley, M., Lai, E. C. and Kunik, M. E. (2009). Telephone-administered cognitive behavioral therapy: a case study of anxiety and depression in Parkinson's disease. Journal of Clinical Psychology in Medical Settings, 16, 243–253.Google Scholar
Weintraub, D. et al. (2006). Association of dopamine agonist use with impulse control disorders in Parkinson disease. Archives of Neurology, 63, 969–973.Google Scholar
Weintraub, D., Moberg, P. J., Duda, J. E., Katz, I. R. and Stern, M. B. (2004). Effect of psychiatric and other non-motor symptoms on disability in Parkinson's disease. Journal of the American Geriatrics Society, 52, 784–788.Google Scholar
Zhang, S. et al. (2016). Management of impulse control disorders in Parkinson's disease. International Psychogeriatrics, 28, 1597–1614.Google Scholar